Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy

BJU International

Volumn 111, Issue 8, 2013, Pages

  Ellis, Carla L ^a   Walsh, Patrick C ^a   Partin, Alan W ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Gleason score 6; needle biopsy; radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROBABILITY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 84878293698     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11680.x     Document Type: Article

References (10)

1. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC,. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003; 169: 517-523 (Pubitemid 36132976)
2. Wang D, Lawton C,. Pelvic lymph node irradiation for prostate cancer: who, why, and when? Semin Radiat Oncol 2008; 18: 35-40 (Pubitemid 350235954)
3. Ohori M, Kattan MW, Koh H, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 2004; 171: 1844-1849 (Pubitemid 38501019)
4. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML,. Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008; 179: 1354-1360
5. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974 (Pubitemid 28445094)
6. Huang Y, Isharwal S, Haese A, et al. Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score. BJU Int 2011; 107: 1562-1569
7. Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005; 173: 1938-1942 (Pubitemid 40675216)
8. May M, Knoll N, Siegsmund M, et al. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a European multicenter survey of 1296 patients. J Urol 2007; 178: 1957-1962 (Pubitemid 47538618)
9. Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA,. Prostate cancer volume at biopsy predicts clinically significant upgrading. J Urol 2008; 179: 896-900
10. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC Jr, for the SEARCH Database Study Group. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 2007; 69: 495-499 (Pubitemid 46428381)